SCHEMBL4658279

SCHEMBL4658279

Cc1ccccc1-c1c(O)ccc2ncccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IL1B P01584 1/20 0.50
ERN1 O75460 1/20 0.46
HTT P42858 4/20 0.46
SLC6A2 P23975 1/20 0.46
KDM4E B2RXH2 7/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 4/20 0.43
KMT2A Q03164 4/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
MAPK1 P28482 1/20 0.43
OPRK1 P41145 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP3A4 P08684 1/20 0.42
ALDH1A1 P00352 3/20 0.40
ALOX12 P18054 2/20 0.40
COMT P21964 1/20 0.40
POLB P06746 1/20 0.40
MPI P34949 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30028810 0.81 KDM4E (0.62) IL1BERN1HTTSLC6A2KDM4E
SCHEMBL21075158 0.81 KDM4E (0.62) IL1BERN1HTTSLC6A2KDM4E
SCHEMBL5652612 0.77 ALDH1A1 (0.46) IL1BHTTKDM4ELMNAKMT2A
SCHEMBL14349104 0.77 KDM4E (0.52) IL1BERN1HTTKDM4EMAPT
SCHEMBL4081624 0.77 IL1B (0.43) IL1BERN1HTTSLC6A2KDM4E
SCHEMBL12023179 0.76 KDM4E (0.50) IL1BERN1HTTKDM4EMAPT
SCHEMBL18685785 0.75 NSD2 (0.54) KDM4EMAPTKMT2AMEN1TDP1
SCHEMBL5547974 0.74 KDM4E (0.58) IL1BERN1HTTSLC6A2KDM4E
Trifluoroacetic Acid SCHEMBL4659454 0.74 IL1B (0.44) IL1BHTTMAPTLMNAKMT2A
SCHEMBL1929285 0.73 KDM4E (0.56) IL1BERN1HTTSLC6A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819342-A4 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2008-12-17 EP disclosed
US-20070293492-A1 Quinoline Tachykinin Receptor Antagonists MERCK SHARP & DOHME CORP. 2007-12-20 US disclosed
CN-101068551-A Quinoline tachykinin receptor antagonists MERCK & CO INC (US) 2007-11-07 CN disclosed
EP-1819342-A1 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-08-22 EP disclosed
WO-2006060390-A1 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293492-A1 Quinoline Tachykinin Receptor Antagonists TACR1, TACR2, NPSR1 IL1B 565/4885ERN1 2775/4885HTT 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.